Allergen (AGN)/Pfizer (PFE) Deal Creates Mid-Teens Synergies in Year 2 - RBC Capital
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- S&P 500, Dow set for higher open with focus on Mideast developments
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Oil falls to two-week low as Gulf supply outlook improves
- Don’t expect a grand bargain from the Trump-Xi summit: Yardeni
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Allergen (AGN) Should Buy Pfizer (PFE), Not the Other Way Around - Analyst
November 2, 2015 7:10 AM ESTRecent news points to Pfizer (NYSE: PFE) in preliminary talks to acquire Allergen (NYSE: AGN). However, according to one analyst, the deal should be the other way around.
Nomura Securities analyst Shibani Malhotra said Allergen... More
Pfizer (PFE) Confirms Discussions with Allergan (AGN)
October 29, 2015 10:10 AM EDTPfizer (NYSE: PFE) notes the announcement by Allergan (NYSE: AGN) that was released earlier today regarding a potential transaction between the companies. Pfizer confirms that it is in preliminary friendly discussions with Allergan in relation to a potential... More
Pfizer (PFE) Offering $375 - $400/Share for Allergan (AGN) Might Seal Deal - Leerink
October 29, 2015 10:07 AM EDTLeerink is out with commentary on Allergan (NYSE: AGN) following news that it and Pfizer (NYSE: PFE) are in talks over a potential deal.
Analyst Jason Gerberry is updating his Pfizer-Allergan model, which assumes at $375 per Allergan share takeover price. The analyst commented:
Following recent speculation that PFE (MP) and AGN are in discussions around a potential merger, we weigh in on (1) price; (2) people factor; (3) AGN M&A... More
Potential Allergan (AGN), Pfizer (PFE) Tie-Up No Surprise But May Take $400 to Get Done
October 29, 2015 9:50 AM EDTFollowing an eye-opening report late Wednesday from the WSJ, Allergan (NYSE: AGN) confirmed this morning that it has been... More
Pre-Open Stock Movers 10/29: (LOCK) (HBI) (AGN) Higher; (STRP) (AFOP) (NXPI) Lower (more...)
October 29, 2015 9:32 AM EDTRevance Therapeutics (Nasdaq: RVNC) 40.3% HIGHER; announced positive 24-week results today from its multi-center BELMONT Phase 2 active comparator study of injectable RT002. The ongoing study for the treatment of glabellar lines in 268 subjects compared the safety,... More
Allergan (AGN) Affirms Talks with Pfizer (PFE)
October 29, 2015 9:31 AM EDTAllergan (NYSE: AGN) confirmed that it has been approached by Pfizer Inc. and is in preliminary friendly discussions regarding a potential business combination transaction. Allergan stated that no agreement has been reached and there can be no certainty that these discussions... More
Pfizer (PFE), Allergan (AGN) in Talks About Blockbuster Deal - WSJ
October 28, 2015 9:34 PM EDTPfizer (NYSE: PFE) and Allergan (NYSE: AGN) are considering a merger the Wall Street Journal reported late Wednesday, citing people familiar with the matter.
Pfizer has approached Allergan about a... More
